Ge, M.; Huang, L.; Ma, Y.; Sun, S.; Wu, L.; Xu, W.; Yang, D.
MLN4924 Treatment Diminishes Excessive Lipid Storage in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease (NAFLD) by Stimulating Hepatic Mitochondrial Fatty Acid Oxidation and Lipid Metabolites. Pharmaceutics 2022, 14, 2460.
https://doi.org/10.3390/pharmaceutics14112460
AMA Style
Ge M, Huang L, Ma Y, Sun S, Wu L, Xu W, Yang D.
MLN4924 Treatment Diminishes Excessive Lipid Storage in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease (NAFLD) by Stimulating Hepatic Mitochondrial Fatty Acid Oxidation and Lipid Metabolites. Pharmaceutics. 2022; 14(11):2460.
https://doi.org/10.3390/pharmaceutics14112460
Chicago/Turabian Style
Ge, Mengxiao, Linlin Huang, Yinjun Ma, Shuangyi Sun, Lijun Wu, Wei Xu, and Dongqin Yang.
2022. "MLN4924 Treatment Diminishes Excessive Lipid Storage in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease (NAFLD) by Stimulating Hepatic Mitochondrial Fatty Acid Oxidation and Lipid Metabolites" Pharmaceutics 14, no. 11: 2460.
https://doi.org/10.3390/pharmaceutics14112460
APA Style
Ge, M., Huang, L., Ma, Y., Sun, S., Wu, L., Xu, W., & Yang, D.
(2022). MLN4924 Treatment Diminishes Excessive Lipid Storage in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease (NAFLD) by Stimulating Hepatic Mitochondrial Fatty Acid Oxidation and Lipid Metabolites. Pharmaceutics, 14(11), 2460.
https://doi.org/10.3390/pharmaceutics14112460